Standout Papers
- Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer (2005)
- Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. (2003)
Immediate Impact
1 by Nobel laureates 28 from Science/Nature 59 standout
Citing Papers
Intercellular interaction dictates cancer cell ferroptosis via NF2–YAP signalling
2019 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Works of Tracy Curley being referenced
Potential Role of Histone Deacetylase Inhibitors in Mesothelioma: Clinical Experience with Suberoylanilide Hydroxamic Acid
2006
Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer.
1993
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tracy Curley | 1252 | 1082 | 324 | 1687 | 51 | 3.3k | |
| Kenneth K. Iwata | 953 | 1738 | 187 | 1921 | 49 | 3.4k | |
| Martine P. Roudier | 1735 | 1632 | 486 | 1293 | 69 | 3.4k | |
| William K. Kelly | 1429 | 992 | 456 | 796 | 49 | 2.7k | |
| L. Rhoda Molife | 1473 | 1257 | 227 | 1293 | 73 | 2.9k | |
| Francesco Caponigro | 1235 | 2276 | 395 | 1969 | 100 | 4.5k | |
| David Chu | 665 | 1044 | 139 | 1065 | 56 | 2.8k | |
| Yan Chen | 996 | 820 | 397 | 1297 | 89 | 2.6k | |
| Michael Millward | 1123 | 1718 | 139 | 1127 | 43 | 2.9k | |
| Linda Janisch | 733 | 2110 | 118 | 1730 | 68 | 3.5k | |
| Paola Capodieci | 551 | 1224 | 529 | 2176 | 30 | 3.6k |
All Works
Loading papers...